Brian Nichols

Brian Nichols

InvestorPlace Contributor

Recent Articles

Yahoo! Inc. (YHOO) Stock Could Be in For a Long Year

By Brian Nichols, InvestorPlace Contributor

Investors don't trust YHOO management, and that's why Yahoo stock will remain under pressure despite presenting a great deal of value.

Macy’s Inc.: Has M Stock Quietly Climbed From the Discount Rack?

By Brian Nichols, InvestorPlace Contributor

M stock has recovered some of its losses from last year, but thankfully, Macy's still has a ways to go before reaching fair value.

It’s Not too Late to Buy These 5 Oil Stocks

By Brian Nichols, InvestorPlace Contributor

If you invest in them with money you're prepared to lose, these five oil stocks to buy can be multi-baggers in your portfolio.

Tesla Motors Inc (TSLA) Stock: Don’t Catch This Falling Knife

By Brian Nichols, InvestorPlace Contributor

Sentiment for Tesla (TSLA) stock is declining, and thanks to recent labor issues and concerns about supply and demand, it probably won't make a comeback soon.

Don’t Make This Mistake With Groupon Stock (GRPN)

By Brian Nichols, InvestorPlace Contributor

Groupon stock is well deserving of its recent gains, but how much higher can GRPN really go? We take a closer look at the stock's valuation.

General Motors Company: The “Lyft” GM Stock Needs

By Brian Nichols, InvestorPlace Contributor

General Motors needs to create some excitement in GM stock, and Lyft might just be the way to do so.

Palo Alto Networks Inc: PANW Is a Huge Risk Ahead of Earnings

By Brian Nichols, InvestorPlace Contributor

PANW has trended downward like nobody's business. Now its pie-in-the-sky earnings outlook could banish Palo Alto's stock further in the trenches.

Will Watson Health Cloud Pay off for International Business Machines Corp.? (IBM)

By Brian Nichols, InvestorPlace Contributor

IBM stock will be propelled by insightful decision's IBM's management is making with Watson Health Cloud.

NKE Stock: Nike Inc Should Take a Page From Under Armour Inc’s Book

By Brian Nichols, InvestorPlace Contributor

For the sake of Nike stock, the company had better pay attention to how UA is doing business and focus on quality over quantity.

Celgene Corporation: Celgene Stock Is a Can’t-Miss Biotech (CELG)

By Brian Nichols, InvestorPlace Contributor

Celgene stock is one of very few biotechs that was undeserving of the recent pullback within the industry.

Load More